Cyteir Therapeutics • CYT
Cyteir Therapeutics Inc is a clinical-stage biotechnology company focused on the development of CYT-0851, an oral investigational drug that inhibits monocarboxylate transporters.
Ratings
0 / 5
0 ratings in the last 12 months
5
4
3
2
1
CEO
Dr. Markus F. Renschler,M.D.$108.7M
Market Cap • 15/03/20242012
(há 12 anos)
2021
(3 years ago)
NASDAQ
Listagem
Lexington
Sede • Massachusetts46
N° de Empregados • 2022Valuation
Company FinancialsValuation Indicators
Valuation IndicatorsRetorno Histórico
CYTSó no Premium...
Visualize o retorno de longo prazo das ações. Dividendos e outros eventos são considerados.